BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35031844)

  • 1. Avoiding contrast-enhanced sequences does not compromise the precision of the simplified MaRIA for the assessment of non-penetrating Crohn's disease activity.
    Fernàndez-Clotet A; Sapena V; Capozzi N; Rodríguez S; Masamunt MC; Ricart E; Ordás I; Panés J; Rimola J
    Eur Radiol; 2022 May; 32(5):3334-3345. PubMed ID: 35031844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the simplified magnetic resonance index of activity by using DWI without gadolinium enhancement to evaluate bowel inflammation in Crohn's disease.
    Bae H; Seo N; Kang EA; Cheon JH; Lim JS; Kim MJ
    Eur Radiol; 2023 May; 33(5):3266-3275. PubMed ID: 36899087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the Simplified Magnetic Resonance Index of Activity [sMARIA] Without Gadolinium-enhanced Sequences for Crohn's Disease.
    Capozzi N; Ordás I; Fernandez-Clotet A; Castro-Poceiro J; Rodríguez S; Alfaro I; Sapena V; Masamunt MC; Ricart E; Panés J; Rimola J
    J Crohns Colitis; 2020 Sep; 14(8):1074-1081. PubMed ID: 32080712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease.
    Ordás I; Rimola J; Rodríguez S; Paredes JM; Martínez-Pérez MJ; Blanc E; Arévalo JA; Aduna M; Andreu M; Radosevic A; Ramírez-Morros AM; Pinó S; Gallego M; Jauregui-Amezaga A; Ricart E; Panés J
    Gastroenterology; 2014 Feb; 146(2):374-82.e1. PubMed ID: 24177375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The new simplified MARIA score applies beyond clinical trials: A suitable clinical practice tool for Crohn's disease that parallels a simple endoscopic index and fecal calprotectin.
    Roseira J; Ventosa AR; de Sousa HT; Brito J
    United European Gastroenterol J; 2020 Dec; 8(10):1208-1216. PubMed ID: 32664824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the magnetic resonance scoring systems for Crohn's disease activity: MaRIA, simplified MaRIA, and Nancy scores.
    Lee WE; Weng MT; Wei SC; Shih IL
    Abdom Radiol (NY); 2023 Jul; 48(7):2228-2236. PubMed ID: 37129624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of sonographic activity scores for adult terminal ileal Crohn's disease compared to magnetic resonance and histological reference standards: experience from the METRIC trial.
    Kumar S; Parry T; Mallett S; Plumb A; Bhatnagar G; Beable R; Betts M; Duncan G; Gupta A; Higginson A; Hyland R; Lapham R; Patel U; Pilcher J; Slater A; Tolan D; Zealley I; Halligan S; Taylor SA;
    Eur Radiol; 2024 Jan; 34(1):455-464. PubMed ID: 37526665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of gadolinium-based contrast agent in the assessment of Crohn's disease activity: Is contrast agent injection necessary?
    Quaia E; Sozzi M; Gennari AG; Pontello M; Angileri R; Cova MA
    J Magn Reson Imaging; 2016 Mar; 43(3):688-97. PubMed ID: 26250897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Performance of Magnetic Resonance Enterography Disease Activity Indices Compared with a Histological Reference Standard for Adult Terminal Ileal Crohn's Disease: Experience from the METRIC Trial.
    Kumar S; Parry T; Mallett S; Bhatnagar G; Plumb A; Walsh S; Scott N; Tandon R; Chong H; du Parcq J; Martinez A; Moorghen M; Rodriguez-Justo M; Halligan S; Taylor SA;
    J Crohns Colitis; 2022 Nov; 16(10):1531-1539. PubMed ID: 35481898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative evaluation of small bowel complications in Crohn's disease: comparison of diffusion-weighted and contrast-enhanced MR imaging.
    Barat M; Hoeffel C; Bouquot M; Jannot AS; Dautry R; Boudiaf M; Pautrat K; Kaci R; Camus M; Eveno C; Pocard M; Soyer P; Dohan A
    Eur Radiol; 2019 Apr; 29(4):2034-2044. PubMed ID: 30302591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing efficiency of MRE for diagnosis of Crohn's disease activity through proper sequence selection: a practical approach for clinical trials.
    Rimola J; Alvarez-Cofiño A; Pérez-Jeldres T; Rodríguez S; Alfaro I; Ordás I; Ricart E; Panés J
    Abdom Radiol (NY); 2017 Dec; 42(12):2783-2791. PubMed ID: 28612164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between magnetic resonance enterography and ileo-colonoscopy for assessment of disease activity in terminal ileal Crohn's disease.
    Kakkar C; Singh A; Mahajan R; Midha V; Goyal S; Narang V; Gupta K; Singh D; Bansal N; Saggar K; Sood A
    Indian J Gastroenterol; 2022 Oct; 41(5):465-474. PubMed ID: 36357600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective comparison of diffusion-weighted magnetic resonance enterography and contrast enhanced computed tomography enterography for the detection of ileocolonic Crohn's disease.
    Yu H; Wang Y; Wang Z; Li J; Lu J; Hu D
    J Gastroenterol Hepatol; 2020 Jul; 35(7):1136-1142. PubMed ID: 31785602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A magnetic resonance enterography index for assessing small bowel Crohn's disease activity.
    Zuo Y; Huang W; Wei J; Lan X
    Quant Imaging Med Surg; 2023 Apr; 13(4):2128-2142. PubMed ID: 37064394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing quality of magnetic resonance enterography and its impact on disease assessment of ileal Crohn's disease.
    Bohra A; Connoley DJ; Con D; Segal JP; Niewiadomski O; Vasudevan A; Langenberg DRV; Kutaiba N
    Intest Res; 2024 Apr; 22(2):152-161. PubMed ID: 38173229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Panenteric capsule endoscopy versus ileocolonoscopy plus magnetic resonance enterography in Crohn's disease: a multicentre, prospective study.
    Bruining DH; Oliva S; Fleisher MR; Fischer M; Fletcher JG;
    BMJ Open Gastroenterol; 2020 Jun; 7(1):. PubMed ID: 32499275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of colonoscopy and magnetic resonance enterography is more useful for clinical decision making than colonoscopy alone in patients with complicated Crohn's disease.
    Sagami S; Kobayashi T; Kikkawa N; Umeda S; Nakano M; Toyonaga T; Okabayashi S; Ozaki R; Hibi T
    PLoS One; 2019; 14(2):e0212404. PubMed ID: 30785943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's disease: correlation with SES-CD and clinical-biological markers.
    Stoppino LP; Della Valle N; Rizzi S; Cleopazzo E; Centola A; Iamele D; Bristogiannis C; Stoppino G; Vinci R; Macarini L
    BMC Med Imaging; 2016 May; 16(1):37. PubMed ID: 27149857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance enterography, colonoscopy, and fecal calprotectin correlate in colonic Crohn's disease.
    Somwaru AS; Khanijow V; Katabathina VS
    BMC Gastroenterol; 2019 Dec; 19(1):210. PubMed ID: 31805875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing pediatric ileocolonic Crohn's disease activity based on global MR enterography scores.
    Pomerri F; Al Bunni F; Zuliani M; Guariso G; Gasparetto M; Giorgi B; Cananzi M; Muzzio PC
    Eur Radiol; 2017 Mar; 27(3):1044-1051. PubMed ID: 27277259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.